Eli Lilly to Invest $6.5 Billion in Texas Manufacturing Hub for Obesity Pill and Other Pipeline Drugs
Wegovy Trial Data Lifts Novo Nordisk as U.S. Market Challenges Weigh on Growth
The Mid-Day Buzz
Viking Therapeutics Shares Tumble 40% After Midstage Obesity Pill Trial Disappoints Investors
Evening Market Recap
Eli Lilly Shares Slide as Obesity Pill Shows Modest Results in Late-Stage Trial
The Mid-Day Buzz
Trump Issues Ultimatum to Pharma CEOs: Cut Drug Prices Within 60 Days or Face Action
Novo Nordisk Stock Craters as Wegovy and Ozempic Forecasts Get Slashed
Pump Radar
Stock Alerts